June 26, 2013
COLUMBUS, Ohio – Charles J. Lockwood, MD, dean of The Ohio State University College of Medicine, vice president for health sciences, professor of obstetrics and gynecology, and the Leslie H. and Abigail Wexner Chair in Medicine recently received the 2013 Giorgio Pardi President’s Distinguished Scientist Award presented by the Society for Gynecologic Investigation. Lockwood was honored with the prestigious international award for his significant lifetime contributions to reproductive science.
Prior to his arrival at Ohio State September 1, 2011, Dr. Lockwood spent the last nine years of his career as the Anita O’Keeffe Young Professor of Women’s Health and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale School of Medicine. Before becoming a faculty member at Yale, he served as the Stanley H. Kaplan Professor and Chair of the Department of Obstetrics and Gynecology at the New York University School of Medicine from 1995 – 2002.
Lockwood earned a Sc.B., magna cum laude, at Brown University; his medical degree at the University School of Medicine; and a Master of Science in health care management at Harvard University. He completed his residency in obstetrics and gynecology at Pennsylvania Hospital and, in addition to a fellowship in maternal-fetal medicine at the Yale-New Haven Hospital. He also completed a postdoctoral fellowship in molecular hemostasis at the Mount Sinai Medical Center in New York City.
Lockwood is internationally known for his research expertise in obstetrics and gynecology, having authored 250 peer-reviewed publications, 80 chapters and invited reviews and over 130 editorials, authoring or co-authoring three books and editing four textbooks on the subject. He is a consistent recipient of research funding support, including multiple awards from the National Institutes of Health (NIH), the March of Dimes and other foundations. His research focuses on endometrial hemostasis and the molecular pathogenesis of preterm birth. He has been credited with assisting with the creation of fetal fibronectin, the first biochemical predictor of prematurity. Among his scientific discoveries is identification of the biochemical mechanisms underlying uterine hemostasis via tissue factor expression.
Lockwood also has extensive service on editorial boards, including the Journal of Clinical Endocrinology and Metabolism and the Journal of Perinatal Medicine, and has served as Editor-in-Chief of Contemporary OB/GYN, for the past 12 years where he has won four national publishing awards for his editorials. He also serves as section editor for obstetrics of “UpToDate,” an online resource for the medical community.
Lockwood is past chair of the American College of Obstetricians and Gynecologists’ Committee on Obstetrical Practice and its Document Review Committee for Obstetrics. He also has previously served on the Council, and has been Secretary-Treasurer and President of the Society for Gynecologic Investigation. In addition, his service to professional organizations includes being a regular member of the FDA’s Reproductive Health Drugs Advisory Committee Panel and regular and/or ad hoc member of multiple NIH study sections.
Among his numerous honors, Lockwood is an elected member of the Institute of Medicine of the National Academies, as well as the Sigma Xi and Alpha Omega Alpha honor societies.
Contact: Sherri Kirk, Public Affairs and Media Relations, 614-293-3737, or Sherri.Kirk@osumc.edu
Prior to his arrival at Ohio State September 1, 2011, Dr. Lockwood spent the last nine years of his career as the Anita O’Keeffe Young Professor of Women’s Health and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale School of Medicine. Before becoming a faculty member at Yale, he served as the Stanley H. Kaplan Professor and Chair of the Department of Obstetrics and Gynecology at the New York University School of Medicine from 1995 – 2002.
Lockwood earned a Sc.B., magna cum laude, at Brown University; his medical degree at the University School of Medicine; and a Master of Science in health care management at Harvard University. He completed his residency in obstetrics and gynecology at Pennsylvania Hospital and, in addition to a fellowship in maternal-fetal medicine at the Yale-New Haven Hospital. He also completed a postdoctoral fellowship in molecular hemostasis at the Mount Sinai Medical Center in New York City.
Lockwood is internationally known for his research expertise in obstetrics and gynecology, having authored 250 peer-reviewed publications, 80 chapters and invited reviews and over 130 editorials, authoring or co-authoring three books and editing four textbooks on the subject. He is a consistent recipient of research funding support, including multiple awards from the National Institutes of Health (NIH), the March of Dimes and other foundations. His research focuses on endometrial hemostasis and the molecular pathogenesis of preterm birth. He has been credited with assisting with the creation of fetal fibronectin, the first biochemical predictor of prematurity. Among his scientific discoveries is identification of the biochemical mechanisms underlying uterine hemostasis via tissue factor expression.
Lockwood also has extensive service on editorial boards, including the Journal of Clinical Endocrinology and Metabolism and the Journal of Perinatal Medicine, and has served as Editor-in-Chief of Contemporary OB/GYN, for the past 12 years where he has won four national publishing awards for his editorials. He also serves as section editor for obstetrics of “UpToDate,” an online resource for the medical community.
Lockwood is past chair of the American College of Obstetricians and Gynecologists’ Committee on Obstetrical Practice and its Document Review Committee for Obstetrics. He also has previously served on the Council, and has been Secretary-Treasurer and President of the Society for Gynecologic Investigation. In addition, his service to professional organizations includes being a regular member of the FDA’s Reproductive Health Drugs Advisory Committee Panel and regular and/or ad hoc member of multiple NIH study sections.
Among his numerous honors, Lockwood is an elected member of the Institute of Medicine of the National Academies, as well as the Sigma Xi and Alpha Omega Alpha honor societies.
###